after cuts, still poor RD management

few good leaders and decision makers. keeping managers who pushed 5S? so many cuts difficult for projects to move foward. too many under achiever managers in WP with little discovery experience

 

What do you expect from a "pharmaceutical" company that doesn't have scientists in its upper management? Merck has top-down problems. Don't expect reorganization to change the direction of a company that has no direction to begin with. Shareholders have their head buried in the sand, IMO.

 

I only buy other pharma stocks. Management needs replacement. Few have pushed product to market. WP has too many executive levels with 2 page resumes. Roger make the changes.